NCT04295096View on ClinicalTrials.gov

Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product

NAUnknownINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

February 29, 2024

Study Completion Date

March 31, 2024

Conditions
Healthy Subject
Interventions
DEVICE

Peripheral blood mononuclear cell apheresis

Peripheral blood mono-nuclear cell donation for tumor immunotherapy study of Universal CAR-T cells

Trial Locations (1)

Unknown

RECRUITING

Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, Shanghai

Sponsors
All Listed Sponsors
collaborator

Nanjing Legend Biotech Co.

INDUSTRY

lead

Jun Zhu

OTHER